Evidence map›Paper›PMID 22407961›Full record

ArticleCytoskeleton (Hoboken, N.J.)2012

The microtubule cytoskeleton is required for a G2 cell cycle delay in cancer cells lacking stathmin and p53.

Bruce K Carney, Victoria Caruso Silva, Lynne Cassimeris

Open access · greenAbstract read
In one paragraph

Article in Cytoskeleton (Hoboken, N.J.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cardiomyocyte proliferation contributes to heart growth in young humans.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bruce K CarneyDepartment of Biological Sciences, Lehigh University, Bethlehem, Pennsylvania 18015, USA.
Victoria Caruso Silva
Lynne Cassimeris
Lehigh University · US

Funding

Signal Transduction by the Microtubule Destabilizer, Stathmin/Oncoprotein 18R15GM100381 · NIGMS · LEHIGH UNIVERSITY · PI CASSIMERIS, LYNNE · 2012 to 2012
$365k
NIGMS NIH HHS R15 GM100381
6 · The paper itself

Abstract

In several cancer cell lines, depleting the microtubule (MT)-destabilizing protein stathmin/oncoprotein18 leads to a G2 cell cycle delay and apoptosis. These phenotypes are observed only in synergy with low levels of p53, but the pathway(s) activated by stathmin depletion to delay the cell cycle are unknown. We found that stathmin depletion caused greater MT stability in synergy with loss of p53, measured by the levels of acetylated α-tubulin and the rate of centrosomal MT nucleation. Nocodazole or vinblastine-induced MT depolymerization abrogated the stathmin-depletion induced G2 delay, measured by the percentage of cells staining positive for several markers (TPX2, CDK1 with inhibitory phosphorylation), indicating that MTs are required to lengthen G2. Live cell imaging showed that stathmin depletion increased time in G2 without an impact on the duration of mitosis, indicating that the longer interphase duration is not simply a consequence of a previous slowed mitosis. In contrast, stabilization of MTs with paclitaxel (8 nM) slowed mitosis without lengthening the duration of interphase, demonstrating that increased MT stability alone is not sufficient to delay cells in G2.

Indexed as

ApoptosisCentrosomeCytoskeletonG2 PhaseHeLa CellsHumansMicrotubulesMitosisNocodazolePaclitaxelPhosphorylationRNA, Small InterferingStathminTubulinTubulin ModulatorsTumor Suppressor Protein p53NocodazolePaclitaxelRNA, Small InterferingStathminSTMN1 protein, humanTP53 protein, humanTubulinTubulin ModulatorsTumor Suppressor Protein p53Vinblastine

Identifiers

PMID22407961
PMCPMC4004097
OpenAlexW1996282336

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.